Zobrazeno 1 - 10
of 14 525
pro vyhledávání: ''
Autor:
Tonya Orchard, Tial TinKai, Rachel M. Cole, A. Courtney DeVries, Rebecca Andridge, Kate Ormiston, Maryam B. Lustberg, Julie Fitzgerald, Monica M. Gaudier-Diaz
Publikováno v:
Nutritional neuroscience. 25(12)
Chemotherapy can result in toxic side effects in the brain. Intake of marine-based omega-3 polyunsaturated fatty acids (n-3 PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), alter brain fatty acids, potentially improving brain funct
Publikováno v:
British Journal of Pharmacology. 179:1338-1352
BACKGROUND AND PURPOSE Prostacyclin mimetics express potent vsoactive effects via prostanoid receptors which are not defined unequivocally, as to date no study has considered sex as a factor. The aim of this study was to determine the contribution of
Publikováno v:
Clinical and Translational Science. 15:771-781
Amiodarone and its main metabolite, desethylamiodarone, are highly distributed to serum lipoproteins such as very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL), which are the carriers of triglyceride and cholesterol. This study aim
Publikováno v:
Hormone Molecular Biology and Clinical Investigation. 43:199-205
Objectives To evaluate the anticancer effects of calcitriol and cholecalciferol against different cell lines of breast cancer in monotherapy settings and in combination with raloxifene. Methods The antiproliferative, anti-migratory, and apoptotic ind
Autor:
Andrey Sivkov, Svetlana Sivkova, Roman V. Gorenkov, Sergey Sivkov, Natalya P. Chernus, Tamara Savina
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-9 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background To determine the effect of genetic polymorphism of drug transporters on the efficacy of treatment with Rosuvastatin, Atorvastatin and Simvastatin in patients with hyperlipidemia. Methods The study consists of 180 patients, aged 40–75 yea
Autor:
Willem A. Dik, Monique T. Mulder, Nikita Martens, Roosmarijn F.H. Lemmers, Adrie J.M. Verhoeven, L. C. van Vark-van der Zee, M. van Hoek, Aloysius G Lieverse, Frank P.J. Leijten, Harm R. Haak, Eric J.G. Sijbrands, A.H. Maas, Pieter J. M. Leenen, C.M. Groot-van Ruijven
Publikováno v:
Atherosclerosis Plus, 44, 43-50. Elsevier Ireland Ltd
Atherosclerosis Plus, Vol 44, Iss, Pp 43-50 (2021)
Atherosclerosis Plus, Vol 44, Iss, Pp 43-50 (2021)
Background and aims: High-density lipoproteins (HDL) of patients with type 2 diabetes mellitus (T2DM) have impaired anti-inflammatory activities. The anti-inflammatory activity of HDL has been determined ex vivo after isolation by different methods f
Autor:
Jiacheng Lai, Qingtong Wang, Meili Dong, Bin Li, Jingshu Ni, Yikun Wang, Chongjian Huang, Yongsheng Han
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-9 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Lipid management is the first line of treatment for decreasing the incidence of cardiovascular events in patients with coronary heart disease (CHD), and a variety of indicators are used to evaluate lipid management. This work analyses the
Publikováno v:
Journal of Shahrekord University of Medical Sciences, Vol 23, Iss 3, Pp 131-138 (2021)
Background and aims: The abnormal increase in blood cholesterol can cause many problems. Statins have a cholesterol-lowering effect, but they also have adverse effects. Garlic prevents the formation of cholesterol due to its antibiotic properties. Th
Autor:
L.L. Pavlovskyi
Publikováno v:
GASTROENTEROLOGY. 54:96-100
Background. Ceramides are the fats of the sphingolipid family that are involved in the development of insulin resistance, non-alcoholic fatty liver disease, and type 2 diabetes. Despite the standards of treatment for these diseases, there is currentl
Autor:
V.V. Poltorak
Publikováno v:
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY; № 4.76 (2016); 59-72
Международный эндокринологический журнал-Mìžnarodnij endokrinologìčnij žurnal; № 4.76 (2016); 59-72
Міжнародний ендокринологічний журнал-Mìžnarodnij endokrinologìčnij žurnal; № 4.76 (2016); 59-72
Международный эндокринологический журнал-Mìžnarodnij endokrinologìčnij žurnal; № 4.76 (2016); 59-72
Міжнародний ендокринологічний журнал-Mìžnarodnij endokrinologìčnij žurnal; № 4.76 (2016); 59-72
This review examines the new formulation of insulin glargine (recombinant) in the form of injections 300 U/ml (Gla‑300, Toujeo®). Gla‑300 is a next generation basal insulin with a novel formulation of insulin glargin delivering the same amount o